These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
796 related items for PubMed ID: 15802886
1. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies]. Langer F, Helsberg K, Schütte WH, Leschinger MI. Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886 [Abstract] [Full Text] [Related]
2. [Treatment of the unresectable non small cell lung carcinoma]. Spásová I. Cas Lek Cesk; 2005 Mar; 144(9):602-12; discussion 612-3. PubMed ID: 16193938 [Abstract] [Full Text] [Related]
17. [A Meta-Analysis of Platinum Plus Gemcitabine or Vinorelbine for Advanced Non-small Cell Lung Cancer.]. Gao G, Zhou X, Huang R, Jiang J, Chu Z, Zhan Q, Liang X. Zhongguo Fei Ai Za Zhi; 2009 Jan 20; 12(1):38-43. PubMed ID: 20712955 [Abstract] [Full Text] [Related]
18. [Efficacy analysis of third-generation plus platinum doublets in the first-line chemotherapy of advanced non-small cell lung cancer]. Zhao LD, Zhang XR, Li JL, Wang ZP, Wang Y, Hao XZ, Hu XS, Zhou SY, Sun Y, Shi YK. Zhonghua Yi Xue Za Zhi; 2012 Jun 12; 92(22):1527-31. PubMed ID: 22944054 [Abstract] [Full Text] [Related]
20. Comparison of the efficacy and safety of single-agent and doublet chemotherapy in advanced non-small cell lung cancer in the elderly: a meta-analysis. Des Guetz G, Uzzan B, Nicolas P, Valeyre D, Sebbane G, Morere JF. Crit Rev Oncol Hematol; 2012 Dec 12; 84(3):340-9. PubMed ID: 22534083 [Abstract] [Full Text] [Related] Page: [Next] [New Search]